Arsenic Induces Apoptosis in Myoblasts Through a Reactive Oxygen Species-induced Endoplasmic Reticulum Stress and Mitochondrial Dysfunction Pathway
Overview
Affiliations
A pool of myoblasts available for myogenesis is important for skeletal muscle size. The decreased number of skeletal muscle fibers could be due to the decreased myoblast proliferation or cytotoxicity. Identification of toxicants that regulate myoblast apoptosis is important in skeletal muscle development or regeneration. Here, we investigate the cytotoxic effect and its possible mechanisms of arsenic trioxide (As(2)O(3)) on myoblasts. C2C12 myoblasts underwent apoptosis in response to As(2)O(3) (1-10 μM), accompanied by increased Bax/Bcl-2 ratio, decreased mitochondria membrane potential, increased cytochrome c release, increased caspase-3/-9 activity, and increased poly (ADP-ribose) polymerase (PARP) cleavage. Moreover, As(2)O(3) triggered the endoplasmic reticulum (ER) stress indentified through several key molecules of the unfolded protein response, including glucose-regulated protein (GRP)-78, GRP-94, PERK, eIF2α, ATF6, and caspase-12. Pretreatment with antioxidant N-acetylcysteine (NAC, 0.5 mM) dramatically suppressed the increases in reactive oxygen species (ROS), lipid peroxidation, ER stress, caspase cascade activity, and apoptosis in As(2)O(3) (10 μM)-treated myoblasts. Furthermore, As(2)O(3) (10 μM) effectively decreased the phosphorylation of Akt, which could be reversed by NAC. Over-expression of constitutive activation of Akt (c.a. Akt) also significantly attenuated As(2)O(3)-induced myoblast apoptosis. Taken together, these results suggest that As(2)O(3) may exert its cytotoxicity on myoblasts by inducing apoptosis through a ROS-induced mitochondrial dysfunction, ER stress, and Akt inactivation signaling pathway.
Role of vitamin D in mitigating sodium arsenite-induced neurotoxicity in male rats.
Abdou H, Saad A, Abd Elkader H, Essawy A Toxicol Res (Camb). 2024; 13(6):tfae203.
PMID: 39611054 PMC: 11602150. DOI: 10.1093/toxres/tfae203.
Zhao J, Han M, Tian Y, Zhao P, Liu X, Dong H Curr Pharm Biotechnol. 2023; 25(11):1466-1477.
PMID: 37921125 DOI: 10.2174/0113892010257526231019143524.
Arsenic and cancer: Evidence and mechanisms.
Speer R, Zhou X, Volk L, Liu K, Hudson L Adv Pharmacol. 2023; 96:151-202.
PMID: 36858772 PMC: 10860672. DOI: 10.1016/bs.apha.2022.08.001.
Ijaz M, Haider S, Tahir A, Afsar T, Almajwal A, Amor H Sci Rep. 2023; 13(1):3080.
PMID: 36813806 PMC: 9947136. DOI: 10.1038/s41598-023-30302-x.
Sahoo K, Sharma A Apoptosis. 2023; 28(3-4):277-292.
PMID: 36611106 DOI: 10.1007/s10495-022-01806-0.